Reserve your place at ISGEDR 2021

Dear Colleague,

Welcome to the Registration Pay for the ISGEDR 2021 Joint Meeting. We offer you first the opportunity to join ISGEDR and consequently qualify for the discounted rate for members and a FREE subscription to the Journal of Ophthalmic Genetics for the coming year.

On this page, and below the links to register for ISGEDR, you will be guided either to register to attend the conference virtually or to attend in person.

You can review the Provisional Programme HERE and make an Abstract Submission HERE.

For more information about the local arrangements and lodgings in Lausanne, VISIT THIS PAGE.

ISGEDR 2021 Lausanne

Dear colleagues and friends,

I have the privilege to announce the 22nd ISGEDR Meeting, which will be held hybrid (virtual and in person) from September 2nd to 4th 2021 in Lausanne, Switzerland, jointly with the European Group of Retinoblastoma (EURbG), the Société de Génétique Ophtalmologique Francophone (SGOF), and the European Reference Network dedi- cated to Rare Eye Diseases (ERN-EYE). The scientific program promises to be outstanding, covering the hotest topics in ocular genetics and retinoblastoma. This will include three named lectures, the Jules-François Lecture by Jean Bennett and Albert Maguire, the Franceschetti Medal and Lecture by Ian MacDonald and the Ellsworth Lecture by David Abramson. Looking forward to meeting you soon.

Francis Munier President of ISGEDR

Please download the Lausanne 2021 Flyer from the link below:

Need a Hand?

ISGEDR 2021 Lausanne – Local Liaison Contact Details

If you have any non-scientific queries, please feel free to contact our Local Liaison, Paolo Caputo at paola.caputo@fa2.ch

Lausanne – Overview

Lausanne – Overview

Lausanne rises elegantly in terraces on three hills above the north shore of Lake Geneva in Switzerland’s French-speaking region. High bridges span the gorges of two rivers that cut through the city, combining with the steep rise from the lakeshore to give Lausanne a dramatic and scenic terrain with views of the Savoy Alps across the lake. An old university city and now a busy commercial one, it is popular for congresses, trade fairs, and conventions, with a number of outstanding meeting venues. Lausanne is the world headquarters of the Olympic Committee, and an Olympic museum is among its most popular tourist attractions.

The Romans established a trading colony here in the first century BC, and by the Middle Age, Lausanne’s cathedral was already important as a pilgrimage stop on the Way of St. James. To sense this old city, wander the winding streets below the cathedral; and to capture the elegance of its late-18th-century grandeur as a highlight of the Swiss Riviera, descend to the shore where Belle Époque hotels line its lakeside promenade.
Visit the links here below to can find more information about Lausanne :

ISGEDR 2021 Lausanne – Meeting Sponsors

Sponsors

The content of this meeting is independent of commercial interests.

Any conflict of interest by the scientific organizers or the presenters will be disclosed in the related presentations, in the meeting proceedings, and on the meeting website. The International Society for Genetic Eye Disease & Retinoblastoma in addition wishes to thank the following sponsors who have generously supported the ISGEDR 2021 Lausanne Meeting:

1A Medical AG

Bayer Schweiz AG

Domedics AG

Genentech

Gensight

Metrovision

Novartis Pharma Schweiz

ProQR

SparingVision

Spark Therapeutics

Théa Phar­ma­ceu­ti­cals

ISGEDR/ERN-EYE Joint GREET Meeting Notes

Aim :

To share one session of the Grand Round ERN-EYE Transnational (GREET held every 2 months) meeting with the ISGEDR meeting.

Duration of the meeting/sesion is 90 minutes: thus 8 -10 cases

 

Principle :

The ISGEDR meeting will hold an ISGEDR / ERN-EYE (www.ern-eye.eu) joint meeting in the format of a GREET (see website page https://www.ern-eye.eu/greet).

The Grand Round ERN-EYE Transnational (GREET) is a meeting organised by ERN-EYE with the aim to share challenging and/or highly and particularly relevant cases and stimulate discussions among experts.

The duration of a case presentation is maximum 5 minutes with 5 minutes discussion.

The topic will be rare eye disease including, inherited retinal degeneration, inherited optic neuropathies developmental anomalies, …

A canevas for presentation is imposed and will be sent to speakers with acceptance email

A selection of 8 cases will be made by the ISGEDR/ERN-EYE committee. The presenter will be informed around the 25 07 2021.

Non selected cases: for ERN-EYE members may be presented on a future GREET and is accessible on CPMS anyhow for all members

For non ERN-EYE members : They can submit an abstract through the ISGEDR website

 

Process to apply  :

Two ways of applying

As ERN-EYE member: follow the ERN-EYE procedure (INCLUDING CPMS upload) , Register on ISGEDR, SUBMIT an GREET ABSTRACT , if selected proceed as ERN-EYE GREET ( including the upload on CPMS)

DEADLINE 30 06 2021

AS NON ERN-EYE member: Register on ISGEDR, Submit a GREET ABSTRACT, DEADLINE on abstract submission JOINT meeting: DEADLINE 30 06 2021

ISGEDR 2021 - Lausanne - Abstract Submission Deadline

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Lausanne 2021 – Abstract Submission Form

Dear Colleague,

If you wish to submit and Abstract to the Organising Committee of ISGEDR 2021 Lausanne Joint Meeting, please complete and submit the form below:

Lausanne 2021 - Abstract Submission Form

Memberships

Preferences

7 + 8 =

Not a Member – JOIN NOW to benefit from Member Discount

You can now purchase your ISGEDR Annual Membership including Renewals right here using our Secure Store below.

Benefits of Membership:

As a benefit of your membership you will receive an electronic subscription to Ophthalmic Genetics, the official publication of the Society.

Additionally, you will eligible for reduced registration fee at the bi-annual meeting. To purchase a membership, click on correct Membership Plan and complete your purchase.

ISGEDR 2021 - Lausanne

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)